IL192325A0 - Method and composition for treating and diagnosing restless legs syndrome - Google Patents

Method and composition for treating and diagnosing restless legs syndrome

Info

Publication number
IL192325A0
IL192325A0 IL192325A IL19232508A IL192325A0 IL 192325 A0 IL192325 A0 IL 192325A0 IL 192325 A IL192325 A IL 192325A IL 19232508 A IL19232508 A IL 19232508A IL 192325 A0 IL192325 A0 IL 192325A0
Authority
IL
Israel
Prior art keywords
treating
composition
restless legs
legs syndrome
diagnosing
Prior art date
Application number
IL192325A
Other languages
English (en)
Original Assignee
Hedner Jan
Grote Ludger
Stenlof Kaj
Cereuscience Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hedner Jan, Grote Ludger, Stenlof Kaj, Cereuscience Ab filed Critical Hedner Jan
Publication of IL192325A0 publication Critical patent/IL192325A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL192325A 2005-12-20 2008-06-19 Method and composition for treating and diagnosing restless legs syndrome IL192325A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0502830 2005-12-20
PCT/SE2006/050553 WO2007073325A1 (en) 2005-12-20 2006-12-06 Method and composition for treating and diagnosing restless legs syndrome

Publications (1)

Publication Number Publication Date
IL192325A0 true IL192325A0 (en) 2009-02-11

Family

ID=38188943

Family Applications (1)

Application Number Title Priority Date Filing Date
IL192325A IL192325A0 (en) 2005-12-20 2008-06-19 Method and composition for treating and diagnosing restless legs syndrome

Country Status (11)

Country Link
US (1) US20090304816A1 (https=)
EP (1) EP1973551A1 (https=)
JP (1) JP2009520023A (https=)
KR (1) KR20080078075A (https=)
CN (1) CN101336109A (https=)
AU (1) AU2006327254A1 (https=)
CA (1) CA2634140A1 (https=)
EA (1) EA200801540A1 (https=)
IL (1) IL192325A0 (https=)
WO (1) WO2007073325A1 (https=)
ZA (1) ZA200805358B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2646250A1 (en) 2006-04-03 2007-10-18 Teva Pharmaceutical Industries Ltd. Use of rasagiline for the treatment of restless legs syndrome
US10617694B2 (en) * 2016-05-11 2020-04-14 Jan Hedner Sultiame for the treatment of sleep apnea

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US6960571B2 (en) * 2003-03-14 2005-11-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
EP1635804B1 (fr) * 2003-05-30 2016-09-21 NLS-1 Pharma AG Utilisation du fer pour le traitement du trouble du deficit de attention/hyper-activite chez les enfants
GB0319874D0 (en) * 2003-08-22 2003-09-24 Glaxo Group Ltd Novel formulation
DE602004031134D1 (de) * 2003-08-29 2011-03-03 Transform Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa

Also Published As

Publication number Publication date
CN101336109A (zh) 2008-12-31
EA200801540A1 (ru) 2008-12-30
US20090304816A1 (en) 2009-12-10
AU2006327254A1 (en) 2007-06-28
CA2634140A1 (en) 2007-06-28
ZA200805358B (en) 2009-04-29
JP2009520023A (ja) 2009-05-21
KR20080078075A (ko) 2008-08-26
EP1973551A1 (en) 2008-10-01
WO2007073325A1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
IL187480A0 (en) Method and composition for treating inflammatory disorders
IL184698A0 (en) Composition and method for improving plant health
EP1899480A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS
PT1877232E (pt) Processo para o tratamento de superfícies de madeira
ZA200803425B (en) Methods and compositions for improving stool quality
EP1921609A4 (en) METHOD OF NOISE SUPPRESSION AND APPARATUS AND COMPUTER PROGRAM
GB0522287D0 (en) Method and compositions
SI2520295T1 (sl) Postopki za preprečevanje in zdravljenje mukozitisa
IL189402A0 (en) Methods and compositions for dried cellular forms
ZA200800346B (en) Catalyst composition and process using same
GB0525314D0 (en) Method and composition
EP1874300A4 (en) METHOD FOR TREATING APATHY SYNDROME
GB0619096D0 (en) Polishing composition and polishing method
IL187531A0 (en) Method and composition for treating osteoarthritis
IL185555A0 (en) Method and composition for treating diabetes
ZA200802969B (en) Composition and method
SG131098A1 (en) Polishing composition and polishing method
ZA200805358B (en) Method and composition for treating and diagnosing restless legs syndrome
GB0524927D0 (en) Compositions and method
IL187161A0 (en) Compositions and methods for treating malaria with cupredoxin and cytochrome
EP1872886A4 (en) SLIDING COMPONENT AND METHOD FOR MANUFACTURING THE SAME
GB0522655D0 (en) Composition and method
GB0511235D0 (en) Compositions and method
GB2432473B (en) Recording apparatus, method and program
GB0519334D0 (en) Method and composition for treating skin